{"view":"<div class=\"w_popup\" id=\"popup_ressources\">\r\n\t<div class=\"overlay\"><\/div> \r\n\t<div data-width=\"500\" data-height=\"350px\" class=\"popup-wrapped\" style=\"width:500px;margin-left:-250px;height:350px;\">\r\n\t\t<div class=\"popup-header\">  \r\n\t\t\t<div>\r\n\t\t\t\tRessources\t\t\t\t<a href=\"\" class=\"popup-close\" data-event=\"w_closePopup\"><i class=\"fa fa-times\"><\/i><\/a>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t<div class=\"popup-body\">\r\n\t\t\t<div style=\"padding:20px;\">\r\n\t<h3 style=\"margin:0\">Precision Medicine: The Future of Pediatric Cancer Treatments<\/h3>\r\n\t<p>The Human Genome Project (an international effort to sequence the entire human genome) opened the door for precision medicine \u2014 developing treatment options based on the genetic makeup of a patient's tumor rather than on the type of cancer they have. Julia Glade Bender, MD, a pediatric oncologist and vice chair for clinical research at Memorial Sloan Kettering Cancer Center, discusses the benefits of this revolutionary approach to treating pediatric cancer.<\/p>\r\n\t<div class=\"action\">\r\n\t\t\t\t<a class=\"button\" target=\"_blank\" href=\"https:\/\/www.youtube.com\/watch?v=gQXVO5ZRp4g\">Consulter<\/a>\r\n\t\t\r\n\t\t\t<\/div>\r\n<\/div>\t\t<\/div>\r\n\t<\/div> \r\n<\/div>"}